Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference300 articles.
1. Dalhoff A. Quinolone resistance in Pseudomonas aeruginosa and Staphylococcus aureus. Development during therapy and clinical significance. Infection. 1994;22(Suppl 2):S111–21.
2. Thauvin-Eliopoulos C, Eliopoulos GM. Chap 5. Activity in vitro of the quinolones. In: Hooper DC, Rubinstein E, editors. Quinolone antimicrobial agents. 3rd ed. Washington DC: ASM Press; 2003. p. 91–111.
3. Dalhoff A. In vitro activities of quinolones. Expert Opin Investig Drugs. 1999;8:123–37.
4. Dalhoff A, Schmitz FJ. In vitro antibacterial activity and pharmacodynamics of new quinolones. Eur J Clin Microbiol Infect Dis. 2003;22:203–21.
5. European Agency for the Evaluation of Medicinal Products (EMEA) press release. EMEA recommends restricted use of oral norfloxacin-containing medicines in urinary infections. Doc. Ref. EMEA/380260/2008. http://www.ema.europa.eu .
Cited by
90 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献